The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system
- 1 February 2020
- journal article
- review article
- Published by Elsevier in Analytical Biochemistry
- Vol. 591, 113556
Abstract
No abstract availableKeywords
Funding Information
- New York State Department of Health (DOH01-C34458GG-3450000)
This publication has 83 references indexed in Scilit:
- Genomic Analysis of Reactive AstrogliosisThe Journal of Neuroscience, 2012
- Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemiaNeurobiology of Disease, 2012
- Transglutaminase 2: A molecular Swiss army knifeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Astrocyte-Derived Tissue Transglutaminase Interacts with Fibronectin: A Role in Astrocyte Adhesion and Migration?PLOS ONE, 2011
- Transforming growth factor-β1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF-κB pathwaysJournal of Neuroinflammation, 2010
- Transglutaminase 2 protects against ischemic strokeNeurobiology of Disease, 2010
- Inflammation in Alzheimer's disease: relevance to pathogenesis and therapyAlzheimer's Research & Therapy, 2010
- Systemic inflammation and disease progression in Alzheimer diseaseNeurology, 2009
- Transglutaminase 2 Is Central to Induction of the Arterial Calcification Program by Smooth Muscle CellsCirculation Research, 2008
- GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasisProceedings of the National Academy of Sciences, 2006